Table 1

The association of BMI with the risk and outcomes of NMOSD-AQP4

NMOSD-AQP4* (n=64)Healthy controls (n=256)NMOSD-AQP4* (n=11)Healthy controls (n=44)
BMI, mean (SD), kg/m2 21.4 (2.9)23 (3.6)23.4 (2.7)23.6 (3.8)
BMI (kg/m2), one unit decrease
OR (95% CI)1.17 (1.06 to 1.28)1.02 (0.83 to 1.24)
P value0.0010.865
  • *The BMI of NMOSD-AQP4 were BMInaive, which is measured within 1 month of their disease onset and measured before the use of steroid treatment.

  • BMI, body mass index; NMOSD-AQP4, neuromyelitis optica spectrum disorder with aquaporin-4 immunoglobulin G.